Clinical Trial Update: Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating supraphysiological doses of levothyroxine as adjunctive therapy for bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Bipolar Disorder | Phase 2, Phase 3 | Status: COMPLETED